MARKETSnap
  • Gainers &
    Losers
  • Most Active &
    More
  • 52-Week
    High/Low
  • P/E
    Ratios
    • Large Caps
    • Absolute
    • Total Market PE
  • Stocks
    Performance
    • Large Caps
    • Absolute
  • Industries
    Performance
    • Industry
    • Sector
  • Dividends
  • 📅 Calendar
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 🔧 Tools
    • 💰 Intrinsic Value Calculator
    • 📈 Compounding Calculator
    • 🤖 Stock Pick Screener
  • More
    • Investment Compounding Calculator
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
603259.SS stock logo

603259.SS

WuXi AppTec Co., Ltd.

$110.53
-0.04
 (-0.04%)
Exchange:  SHH
Market Cap:  273.372B
Shares Outstanding:  2.913B
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Healthcare
Industry:  Medical – Diagnostics & Research
   
CEO:  Ge Li
Full Time Employees:  39414
Address: 
288 Fute Zhong Road
Shanghai
200131
CN
Website:  https://www.wuxiapptec.com
WuXi AppTec Co., Ltd., an investment holding company, provides research, development, and manufacturing services to discover, develop, and manufacture small molecule drugs, and cell and gene therapies in the People’s Republic of China, rest of Asia, the United States, Europe, and internationally. The company operates through six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions that support stand-alone and integrated projects from target discovery to candidate selection and into the clinic. The company also provides seamless drug and medical device testing services from preclinical testing to clinical trials; an integrated end-to-end solution to accelerate time to market for cell and gene therapies; drug discovery services to pharmaceutical and biotech customers; and clinical research services. WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People’s Republic of China.

Click to read more…

Revenue Segmentation

🔒 You are currently logged out

Login

It’s free

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

No earnings call materials on file for this symbol yet.

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue38,678,00037,917,78245,456,166
Gross Profit14,912,18716,490,19821,654,731
EBITDA11,885,05914,545,64627,686,525
Operating Income11,872,28613,419,66817,004,941
Net Income9,606,7499,450,30819,187,679

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets73,669,34980,325,824103,120,969
Total Liabilities18,151,90421,240,21122,873,255
Total Stockholders Equity55,122,45458,632,71579,712,290
Total Debt5,452,6294,748,7598,420,113
Cash and Cash Equivalents13,764,05919,556,01829,468,519

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow13,386,91212,406,51517,592,412
Capital Expenditure-5,516,559-4,003,493-5,538,151
Free Cash Flow7,870,3538,403,02212,054,261
Net Income9,606,749.1439,450,30819,150,582
Net Change in Cash2,017,1353,443,67216,012,112

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2028Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Low)69,170,643.114Full AccessFull AccessFull AccessFull Access
Estimated Revenue (High)69,297,224.083Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Avg)69,233,933.599Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Low)25,000,556.020Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (High)25,046,306.564Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Avg)25,023,431.292Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Low)21,165,128.558Full AccessFull AccessFull AccessFull Access
Estimated Net Income (High)24,912,291.859Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Avg)22,863,289.960Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Low)1,973,555.733Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (High)1,977,167.303Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Avg)1,975,361.518Full AccessFull AccessFull AccessFull Access
Estimated EPS (Avg)7.830Full AccessFull AccessFull AccessFull Access
Estimated EPS (High)8.550Full AccessFull AccessFull AccessFull Access
Estimated EPS (Low)7.260Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated Revenue)15Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated EPS)13Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
  ?P/S
 (TTM)
: 
5.41
?Net Income
 (TTM)
: 
  ?P/E
 (TTM)
: 
12.17
?Enterprise Value
 (TTM)
: 
224.771B  ?EV/FCF
 (TTM)
: 
18.74
?Dividend Yield
 (TTM)
: 
0.02  ?Payout Ratio
 (TTM)
: 
0.31
?ROE
 (TTM)
: 
0.28  ?ROIC
 (TTM)
: 
0.18
?Net Debt
 (TTM)
: 
  ?Debt/Equity
 (TTM)
: 
0.11
?P/B
 (TTM)
: 
2.92  ?Current Ratio
 (TTM)
: 
3.15

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Full Access for high/low estimates and the interactive table.

Forward P/E 1YFull AccessFull AccessFull AccessFull Access
135.55Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.


Calculate SS Intrinsic Value

Common questions about 603259.SS valuation

Is WuXi AppTec Co., Ltd. (603259.SS) overvalued or undervalued right now?

MARKETSnap estimates intrinsic value for WuXi AppTec Co., Ltd. (603259.SS) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is 603259.SS a buy, hold, or sell for long-term investors?

MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether 603259.SS trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is 603259.SS’s P/E ratio?

You can see 603259.SS’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for 603259.SS?

MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is 603259.SS a good long-term investment?

Whether 603259.SS fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

603259.SS

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

-0.04
MARKETSnap

Trading Metrics:

Open: 111   Previous Close: 110.57
Day Low: 110   Day High: 114.5
Year Low: 57.92   Year High: 115.79
Price Avg 50: 98.26   Price Avg 200: 98.1
Volume: 64.342M   Average Volume: 39.108M

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free
Could not create stock discussion for SS

Relevant news

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States
  • Gainers & Losers
  • Most Active & More
  • 52-Week High/Low
  • Dividends
    • Large Caps
    • Absolute
    • Total Market PE
    • Large Caps
    • Absolute
    • Industry
    • Sector
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 💰 Stock intrinsic value Calculator
  • 📈 Investment Compounding Calculator
  • 🤖 Stock Pick Screener
  • 📋 Watchlist & Portfolio
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Nexus
  • Login Login
  • Profile Profile
  • Watchlists Watchlists
  • My Valuations My Valuations
  • Settings Settings

Media

Watch Listen Read